You searched for "ears"
ENT in this issue...The Future of ENT (Mar/Apr19)
Chris CoulsonENT Surgeon; Managing Director of endoscope-i E: chris@endoscope-i.com The future, predict it at your peril’, said me – just now. But despite this (rather late) warning, we have managed to commission five articles from futurists within our midst. The...In conversation with Robin Youngs
Members of ENT UK (The British Association of Otolaryngologists and Head and Neck Surgeons) have a long tradition of humanitarian work in countries in Africa and Asia (see article with Professor Davis Howard in previous issue for example). The ENT...What I look for at a conference (and why you should go to BACO 2023)
Professor Claire Hopkins has attended more than her fair share of international meetings, and she shares her top tips. COVID has changed the face of medical education forever – who would have thought only a few years ago that we...Global Ambassadors Highlights of the Year
Audiology, Indian Subcontinent, Krishna Yerraguntla Over 466-million people live with disabling hearing loss and global costs of unaddressed hearing loss is 750-billion international dollars. Thus, to alleviate the impact of hearing loss on lives of people, The World Hearing Day...In this issue...Inner Ear Therapeutics
Emma Stapleton, MBChB, FRCS (ORL-HNS), Consultant Otolaryngologist, Cochlear Implant and Skull Base Surgeon, Manchester Royal Infirmary, UK. E: emmastapleton@doctors.org.ukTwitter: @otolaryngolofox Ralph Holme, Director of Research and Insight, RNID, UK. Ralph. E: Holme@rnid.org.uk W: www.rnid.org.uk For Mar/Apr 2022, we sang the...
A raised neutrophil / lymphocyte ratio predicts vestibular schwannoma growth
It has long been known that the neutrophil to lymphocyte count ratio (NLR) is a marker of inflammation and that a higher ratio relates to poorer outcomes in some malignant tumours including some head and neck cancers. Neutrophilia (and therefore...
Does cholesteatoma surgery affect school performance?
While much focus has been placed on short-term complications associated with cholesteatoma, a lack of knowledge remains about the impact suffering from cholesteatoma in childhood may have on educational outcome. The aim of the study was to investigate whether suffering...
High dose betahistine as effective as, but slower acting compared to intratympanic dexamethasone in intractable Meniere’s disease
The management of intractable Meniere’s disease poses a complex conundrum to otolaryngologists. The focus of treatment is decreasing the severity and frequency of vertigo and tinnitus whilst trying to preserve hearing. Betahistine has been used for many years in the...
A trial of house dust mite sublingual tablet in children with allergic rhinitis
The house dust mite (HDM) is one of the commonest causative agents in allergic rhinitis (AR), affecting patients across all demographics. Recently, sublingual immunotherapy (SLIT) has been shown in clinical trials and meta-analysis to be effective compared to placebo in...Are today’s implantable hearing devices better than conventional devices for patients with conductive and mixed hearing loss?
In March 2014, we published a paper in ENT & Audiology News, with a similar title. Below, an updated overview is presented of available devices (early 2021) for patients with conductive/mixed hearing loss. The focus is on effectiveness. Patients with...Rask-Andersen made honorary member of ENT UK
The inner-ear research laboratory at the University of Uppsala in Sweden has a long tradition of ear research. The department has been linked to such legendary names as Barany (Nobel Laureate), Nylen and Stahle. Now, the head of that department, Professor Helge Rask-Andersen, has been awarded honorary membership of ENT UK.
